NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Wednesday that revenues for the first quarter rose 12 percent year over year driven by double-digit growth in all regions and led by the Molecular Diagnostics and Applied Testing customer classes.

The company also announced organization changes with the creation of two new business areas and changes in leadership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.